In line with these results, CD146 is considered a hallmark of tumor progression and metastasis, especially in TNBC (Li et al., 2021) and CD45 was found deregulated in breast stroma of BC patients at early stages also (Marino et al., 2020). This evidence concerns the gene MCAM and breast cancer.